(Fighting against New Coronary Pneumonia) Russian media pays attention to "China action": understand China's anti-epidemic process from the white paper on anti-epidemic
China News Agency, Beijing, June 8 (Zhang Shuo): Chinese officials released a white paper on "China Action Against New Coronary Pneumonia" on the 7th (hereinafter referred to as the "white paper"). China's anti-epidemic measures and results have been highly concerned by many Russian mainstream media.
The Russian national government newspaper "Russian Daily" commented on the 7th that China's anti-epidemic struggle has fully demonstrated China's governance capabilities and institutional superiority.
The article details the history of China's anti-epidemic disease, describes the effective measures taken in the process of prevention and control of the global pandemic, shares the experience and practices of China's anti-epidemic disease with the international community, and emphasizes this to boost confidence in global anti-epidemic 1. The importance of advancing international anti-epidemic cooperation.
The article points out that the white paper has let the international community fully understand that China has adopted the most comprehensive and stringent measures, which not only protects people's lives and health, but also makes important contributions to the public health of the region and the world. The article said that after this crisis test, the Chinese people are full of confidence in their own political system. They believe that only unity and joint action can overcome the epidemic.
In addition, the "Labor News" also published an article that the number of confirmed cases continued to decline, thanks to the strong measures taken by the Chinese government. "At a critical moment, see the advantages of China's system."
TASS and News have a lot of knowledge about international cooperation in vaccine research and development in China. In an article entitled "Russian-Chinese General Cooperative Research and Development of New Coronavirus Vaccine" published by TASS on the 7th, China's Vice Foreign Minister Ma Zhaoxu said that as a comprehensive strategic cooperation partner in the new era, China and Russia have been actively developing anti-epidemic cooperation and will comply with it. The important consensus reached by the two heads of state further strengthens cooperation in the field of epidemic prevention and control, including vaccine research and development, and jointly contributes to the solidarity of the international community in combating epidemics.
RIA Novosti and the Russian Business Consulting Network (RBC) focused on the news that the Chinese government plans to provide vaccines to the world after completing development and testing. The report quoted Wang Zhigang, Minister of Science and Technology of China, as saying that five vaccines are currently under development, some of which are already being tested. He emphasized that vaccine development will place safety, effectiveness and accessibility in an important position. In addition, international cooperation should be strengthened in both vaccine development and clinical trial application.
The Russian "REGNUM" news network focuses on China's generosity for the global shortage of anti-epidemic materials. The report pointed out that China provided two batches of USD 50 million in cash assistance to WHO. As of May 31, China had sent 29 medical expert teams to 27 countries, and had provided or was providing anti-epidemic assistance to 150 countries and 4 international organizations.
On the 7th, Tass News Agency stated in an article entitled "China Has Suspended Debt Repayment to 77 Developing Countries and Regions" that China has actively participated in and implemented the "Government Debt Repayment Initiative for the Poorest Countries" of the G20, which has been announced Suspended debt repayment to 77 developing countries and regions. The article pointed out that China will also provide more assistance to African countries. The article quoted Chinese official media reports that the cooperation mechanism for 30 Chinese-African counterpart hospitals is being stepped up.
In addition, TASS reported on the prevention and control of the epidemic in China. The article describes in detail China's actions from December 27, 2019 to the end of May 2020 in response to the outbreak. The article, titled "The Per Capita Medical Expenses of Diagnosed Patients in China is about 32,000 to 140,000 yuan", introduces the Chinese government's treatment measures for domestically diagnosed patients. According to the report, "the cost of treating some critically ill patients is hundreds of thousands of yuan or even millions (RMB, the same below), all borne by the state." In addition, the article quoted a white paper that pointed out that as of the end of May, the cumulative cure rate of confirmed cases in China was 94.3%, and the total medical cost of diagnosed inpatients in China was 1.35 billion yuan. (Finish)